phase readout
savePhase 1 primary completion: Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
November 30, 2026updated 12d ago
community read0 votes
Sponsor: Replimune, Inc.. Status: Active, not recruiting. Conditions: Advanced Solid Tumor. NCT04735978.
view source ↗Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that